ProSciento, Inc.

Feb 06, 2020

ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH)

Apr 10, 2019

Second Edition Textbook, 'Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease,' Provides Roadmap for Preclinical and Clinical Research

Dec 05, 2018

ProSciento Forms NASH Roundtable, a Collaborative Forum of Leading Academic and Clinical Development Experts, to Advise Biopharma Drug Development Programs

Aug 06, 2018

ProSciento Expands Executive Team, Appoints Brian Mooney Chief Operating Officer

Jun 19, 2018

ProSciento Appoints Dr. Carine Beysen, Industry Expert in Stable Isotope Research, to Senior Scientific Team

May 23, 2018

ProSciento Appoints Pete Nieto as Vice President of Business Development

Mar 07, 2018

ProSciento Expands Asia Pacific Operations with Office in Australia

Jun 07, 2017

ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment

May 30, 2017

ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors